abstract |
A transdermal absorption preparation containing at least one drug selected from oxybutynin and pharmaceutically acceptable salts thereof, and at least 0.05 mass%, in terms of the total amount of the transdermal absorption preparation, of a sterol selected from cholesterol, cholesterol derivatives, and cholesterol analogs. |